Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Amortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Legend Biotech (LEGN) Cost of Revenue (2019 - 2025)

Legend Biotech filings provide 7 years of Cost of Revenue readings, the most recent being $64.2 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 31.29% to $64.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $205.8 million, a 39.59% increase, with the full-year FY2025 number at $205.8 million, up 39.53% from a year prior.
  • Cost of Revenue hit $64.2 million in Q4 2025 for Legend Biotech, up from $52.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $33.7 billion in Q4 2023 to a low of $16.8 million in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $28.8 million (2022), compared with a mean of $2.4 billion.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 204896.18% in 2021 and later crashed 99.85% in 2024.
  • Legend Biotech's Cost of Revenue stood at $52.8 million in 2021, then crashed by 51.1% to $25.8 million in 2022, then skyrocketed by 130314.75% to $33.7 billion in 2023, then crashed by 99.85% to $48.9 million in 2024, then surged by 31.29% to $64.2 million in 2025.
  • The last three reported values for Cost of Revenue were $64.2 million (Q4 2025), $52.6 million (Q3 2025), and $48.1 million (Q2 2025) per Business Quant data.